Premium
MacroGenics Inc (MGNX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. The company's strategy includes leveragin... Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. The company's strategy includes leveraging partnerships with a therapeutic focus geared toward developing a broad portfolio of pipeline candidates. The company also targets autoimmune disorders and infectious diseases. The company's intellectual property is characterized by its patent use to protect the composition of its product candidates and the technology used to create them. Show more
ROCKVILLE, MD, Dec. 02, 2024 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing...
ROCKVILLE, MD, Nov. 06, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
Strengthened financial position resulting from recently announced MARGENZA® transaction and previously announced receipt of milestone payment from Incyte related to advancement of...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.175 | 5.83333333333 | 3 | 3.365 | 2.91 | 683948 | 3.12796175 | CS |
| 4 | -0.105 | -3.2012195122 | 3.28 | 3.6 | 2.91 | 547089 | 3.19832389 | CS |
| 12 | -0.5313 | -14.3350511292 | 3.7063 | 5.1 | 2.91 | 578058 | 3.52371894 | CS |
| 26 | -2.375 | -42.7927927928 | 5.55 | 5.67 | 2.91 | 668047 | 3.57955238 | CS |
| 52 | -9.995 | -75.8921791951 | 13.17 | 21.88 | 2.91 | 1321554 | 8.20371958 | CS |
| 156 | -8.065 | -71.7526690391 | 11.24 | 21.88 | 2.13 | 949040 | 6.92995518 | CS |
| 260 | -7.165 | -69.2940038685 | 10.34 | 36.4804 | 2.13 | 946761 | 13.35243738 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
